Our mission

We push the boundaries of molecular diagnostics through quantitative technologies.

BillionToOne

BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible for all. Our patent-pending QCT molecular counter platform is the only technology platform that can accurately count the DNA molecules to the single-count level.

We're Hiring!

Our Technology

QCT Molecular Counting Platform

Our QCT (Quantitative Counting Templates) molecular counter technology uses specifically designed molecular standards that encode the molecular count information in sequencing data in a way that can be decoded using machine learning algorithms (4 US/PCT patents pending). This allows us to get extremely quantitative molecular counting information from any sequencing technology.

Our Publications

Collaborate With Us

BillionToOne Inc. is conducting multiple studies on the clinical utility and clinical validity of the single-gene NIPT test. If you are interested in collaboration, email us at support@billiontoone.com

Baylor College of Medcine Yashoda Hospitals NIH SBIR STTR